文献速递肝病

普通人群MAFLD高患病率:大型横断面研究呼吁公共卫生行动

High prevalence of MAFLD in general population: A large cross-sectional study calls for concerted public health action.
PubMed 文献 · Aliment Pharmacol Ther · 2024-02-06

在印度德里随机选取6146名普通人群进行横断面研究,MAFLD患病率为56.4%,其中瘦型MAFLD占11.3%。MAFLD组晚期肝纤维化比例是 non-MAFLD 组的3倍(6.2% vs 1.8%,p<0.001),肥胖与纤维化显著相关。

要点

  • 普通人群MAFLD患病率高达56.4%,瘦型MAFLD占11.3%。
  • MAFLD患者晚期肝纤维化风险约为非MAFLD者的3倍。
  • 高龄、低教育水平、高社会经济阶层和低体力活动与MAFLD相关。

核心结论

  • 研究人群中近半数患有MAFLD,且晚期肝纤维化在MAFLD组中更为常见。
  • 亟需采取积极的公共卫生措施以提高认识并引入干预策略。

研究设计与样本

  • 在印度德里随机选取区域进行的横断面研究,共纳入6146名参与者(平均年龄43.1±13.9岁,48.1%为男性)。
  • 收集社会人口学、健康状况和生活方式数据,并进行人体测量、瞬时弹性成像和实验室检查。

主要发现

  • MAFLD患病率为56.4%(n=3468),其中瘦型MAFLD占11.3%。
  • MAFLD组中高龄(OR: 2.47; 95% CI: 2.21-2.76)、低教育水平(OR: 1.23; 95% CI: 1.09-1.39)、高社会经济阶层(OR: 1.32; 95% CI: 1.17-1.49)和低体力活动(OR: 1.15; 95% CI: 1.03-1.28)更常见。
  • 女性与MAFLD的关联在<40岁组(OR: 0.64; 95% CI: 0.55-0.75)和>40岁组(OR: 1.40; 95% CI: 1.22-1.62)中方向和大小不同(p<0.001)。
  • 研究人群中23%存在肝纤维化(MAFLD组为32.2%),晚期肝纤维化在MAFLD组中为6.2% vs 1.8%(p<0.001)。
  • 肥胖与纤维化有统计学显著关系,75.8%的晚期纤维化个体患有肥胖。

临床怎么用

  • 在普通人群健康筛查中应关注MAFLD的高患病率,尤其对高龄、低教育水平、高社会经济阶层和低体力活动者。
  • 对MAFLD患者应评估肝纤维化,晚期纤维化风险约3倍于非MAFLD者,肥胖者尤需注意。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Metabolic associated fatty liver disease (MAFLD) is a relatively new term with limited studies done in South Asian population. AIM: To determine prevalence and clinico-epidemiological characteristics of MAFLD in general population. METHODS: A cross-sectional study was conducted in randomly selected regions across Delhi, India. Data were collected on socio-demographic particulars, health status and lifestyle factors. Anthropometric measurements, transient elastography, and laboratory investigations were carried out. RESULTS: Altogether 6146 participants (mean age: 43.1 ± 13.9 years, 48.1% males) were included. The prevalence of MAFLD was 56.4% (n = 3468), of which lean MAFLD constituted 11.3%. Higher age (OR: 2.47; 95% CI: 2.21-2.76), low education level (OR: 1.23; 95% CI: 1.09-1.39), upper socio-economic class (OR: 1.32; 95% CI: 1.17-1.49), and low physical activity (OR: 1.15; 95% CI: 1.03-1.28) were more common in MAFLD. The association of female sex with MAFLD differed in age groups <40 years (OR: 0.64 and 95% CI: 0.55-0.75) and >40 years (OR: 1.40 and 95% CI: 1.22-1.62) in both magnitude and direction (p < 0.001). Liver fibrosis was present in 23% of the study population (32.2% among MAFLD group). Advanced liver fibrosis was three times more common in MAFLD group (6.2% vs 1.8%, p < 0.001). Obesity and fibrosis had a statistically significant relationship and 75.8% of the individuals with advanced stages of fibrosis had obesity. CONCLUSION: Nearly half of study population was found to have MAFLD. Advanced hepatic fibrosis was three times more common in these subjects. Aggressive public health measures are urgently required to raise awareness and introduce interventional strategies.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Prabhakar T, Prasad M, Kumar G, et al. High prevalence of MAFLD in general population: A large cross-sectional study calls for concerted public health action. Aliment Pharmacol Ther. 2024. PMID: 38321716. doi:10.1111/apt.17892

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。